explore
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Eyeing GLP
Next article: Eyeing GLP
hotspot
hotspot
-
FDA poised to publish guidelines for clinical trial diversity
2025-09-10 14:10 -
Texas Medical Board asked to define abortion emergency exception
2025-09-10 13:38 -
Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again
2025-09-10 13:09 -
Listen: A conversation with researcher Kevin Esvelt on biosecurity
2025-09-10 12:47 -
340B reform proposal comes out of Senate working group
2025-09-10 12:47 -
Reports of telehealth's death have been greatly exaggerated
2025-09-10 12:21